Annual Total Liabilities
$170.18 M
+$5.94 M+3.62%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual total liabilities is $170.18 million, with the most recent change of +$5.94 million (+3.62%) on December 31, 2023.
- During the last 3 years, PSTX annual total liabilities has risen by +$60.67 million (+55.40%).
Performance
PSTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$206.37 M
-$31.50 M-13.24%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly total liabilities is $206.37 million, with the most recent change of -$31.50 million (-13.24%) on September 30, 2024.
- Over the past year, PSTX quarterly total liabilities has dropped by -$31.50 million (-13.24%).
Performance
PSTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PSTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.6% | -13.2% |
| 3 y3 years | +55.4% | +84.6% |
| 5 y5 years | +39.7% | - |
PSTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -33.5% | -13.2% | -45.2% |
| 5 y | 5-year | -42.6% | -35.6% | -52.2% | -48.7% |
| alltime | all time | -42.6% | -65.3% | -52.2% | -48.7% |
Poseida Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $206.37 M(-13.2%) |
| Jun 2024 | - | $237.87 M(+33.6%) |
| Mar 2024 | - | $177.99 M(+4.6%) |
| Dec 2023 | $170.18 M(+3.6%) | $170.18 M(-4.7%) |
| Sep 2023 | - | $178.59 M(+22.4%) |
| Jun 2023 | - | $145.91 M(-6.5%) |
| Mar 2023 | - | $156.06 M(-5.0%) |
| Dec 2022 | $164.24 M(+45.2%) | $164.24 M(+0.0%) |
| Sep 2022 | - | $164.17 M(+17.6%) |
| Jun 2022 | - | $139.66 M(-3.3%) |
| Mar 2022 | - | $144.45 M(+27.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $113.10 M(+3.3%) | $113.10 M(+1.2%) |
| Sep 2021 | - | $111.78 M(-0.7%) |
| Jun 2021 | - | $112.53 M(+6.3%) |
| Mar 2021 | - | $105.85 M(-3.3%) |
| Dec 2020 | $109.52 M(-63.1%) | $109.52 M(+0.2%) |
| Sep 2020 | - | $109.33 M(-74.7%) |
| Jun 2020 | - | $431.65 M(+295.1%) |
| Mar 2020 | - | $109.26 M(-63.2%) |
| Dec 2019 | $296.51 M(+143.4%) | $296.51 M |
| Dec 2018 | $121.84 M(+106.5%) | - |
| Dec 2017 | $59.00 M | - |
FAQ
- What is Poseida Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Poseida Therapeutics?
- What is Poseida Therapeutics annual total liabilities year-on-year change?
- What is Poseida Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly total liabilities year-on-year change?
What is Poseida Therapeutics annual total liabilities?
The current annual total liabilities of PSTX is $170.18 M
What is the all time high annual total liabilities for Poseida Therapeutics?
Poseida Therapeutics all-time high annual total liabilities is $296.51 M
What is Poseida Therapeutics annual total liabilities year-on-year change?
Over the past year, PSTX annual total liabilities has changed by +$5.94 M (+3.62%)
What is Poseida Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PSTX is $206.37 M
What is the all time high quarterly total liabilities for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly total liabilities is $431.65 M
What is Poseida Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PSTX quarterly total liabilities has changed by -$31.50 M (-13.24%)